A Controlled Trial of a Single Dose of Azithromycin for the Treatment of Chlamydial Urethritis and Cervicitis

New England Journal of Medicine

Volumn 327, Issue 13, 1992, Pages 921-925

  Martin, David H ^a   Mroczkowski, Tomasz F ^a   Dalu, Z A ^b   Mccarty, James ^c   Jones, Robert B ^d   Hopkins, Scott J ^e   Johnson, Raymond B ^e  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b St Louis County Department of Health   (United States)

^c California Medical Research Group   (United States)

^d University of Miami (FL) School of Medicine   (United States)

^e PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; DOXYCYCLINE;

ADOLESCENT; ADULT; ARTICLE; BACTERIUM CULTURE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG HALF LIFE; DRUG RESPONSE; DRUG TISSUE LEVEL; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; NONSPECIFIC URETHRITIS; ORAL DRUG ADMINISTRATION; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; UTERINE CERVICITIS;

EID: 0026778726     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199209243271304     Document Type: Article

References (22)

1. Washington AE, Johnson RE, Sanders LL Jr. Chlamydia trachomatis infections in the United States: what are they costing us? JAMA 1987; 257: 2070–2.
2. Chow JM, Yonekura ML, Richwald GA, Greenland S, Sweet RL, Schachter J. The association between Chlamydia trachomatis and ectopic pregnancy: a matched-pair, case–control study. JAMA 1990; 263: 3164–7.
3. Patton DL. Experimental systems. In: Bowie WR, Caldwell HR, Jones RB, et al., eds. Chlamydial infections: proceedings of the Seventh International Symposium on Human Chlamydial Infections, Harrison Hot Springs, B.C. Cambridge, England: Cambridge University Press, 1990:223–31.
4. Hammerschlag MR. Chlamydial infections. J Pediatr 1989; 114: 727–34.
5. Cramer JA, Scheyer RD, Mattson RH. Compliance declines between clinic visits. Arch Intern Med 1990; 150: 1509–10.
6. Slaney L, Chubb H, Ronald AR, Brunham R. In-vitro activity of azithromycin, erythromycin, ciprofloxacin and norfloxacin against Neisseria gonorrhoeae, Haemophilus ducreyi, and Chlamydia trachomatis. J Antimicrob Chemother 1990; 25: Suppl A: 1–5.
7. Scieux C, Bianchi A, Chappey B, Vassias I, Pérol Y. In-vitro activity of azithromycin against Chlamydia trachomatis. J Antimicrob Chemother 1990; 25: Suppl A: 7–10.
8. Ryan RW, Kwasnik I, Tilton RC. In vitro activity of the macrolide CP 62993-XZ450 against selected microorganisms. In: Program and abstracts of the 26th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, September 28—October 1, 1986. Washington, D.C.: American Society for Microbiology, 1986:267.
9. Krohn K. Gynaecological tissue levels of azithromycin. Eur J Clin Microbiol Infect Dis 1991; 10: 864–8.
10. Jones RB, Van Der Pol B, Martin DH, Shepard MK. Partial characterization of Chlamydia trachomatis isolates resistant to multiple antibiotics. J Infect Dis 1990; 162: 1309–15.
11. Steingrimsson O, Olafsson JH, Thorarinsson H, Ryan RW, Johnson RB, Tilton RC. Azithromycin in the treatment of sexually transmitted disease. J Antimicrob Chemother 1990; 25: Suppl A: 109–14.
12. Rylander M, Hallander HO. In vitro comparison of the activity of doxycycline, tetracycline, erythromycin and a new macrolide, CP 62993, against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma ureaiyticum. Scand J Infect Dis Suppl 1988; 53: 12–7.
13. Renaudin H, Bébéar C. Comparative in vitro activity of azithromycin, clarithromycin, erythromycin and lomefloxacin against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum. Eur J Clin Microbiol Infect Dis 1990; 9: 838–41.
14. Bowie WR, Wang S-P, Alexander ER, et al. Etiology of nongonococcal urethritis: evidence for Chlamydia trachomatis and Ureaplasma urealyticum. J Clin Invest 1977; 59: 735–42.
15. Baldwin DR, Wise R, Andrews JM, Ashby JP, Honeybourne D. Azithromycin concentrations at the sites of pulmonary infection. Eur Respir J 1990; 3: 886–90.
16. Gladue RP, Snider ME. Intracellular accumulation of azithromycin by cultured human fibroblasts. Antimicrob Agents Chemother 1990; 34: 1056–60.
17. de Duve C, de Barsy T, Poole B, Trouet A, Tulkens P, Van Hoof F. Lysosomotropic agents. Biochem Pharmacol 1974; 23: 2495–531.
18. Foulds G, Shepard RM, Johnson RB. The pharmacokinetics of azithromycin in human serum and tissues. J Antimicrob Chemother 1990; 25: Suppl A: 73–82.
19. Stamm WE. Problems in the treatment of bacterial sexually transmitted diseases. Am J Med 1987; 82: Suppl 4A: 307–10.
20. Bell TA, Farrow JA. Compliance with treatment for sexually transmitted diseases. Semin Adolesc Med 1987; 3: 153–6.
21. Shepard MK, Jones RB. Recovery of Chlamydia trachomatis from endometrial and fallopian tube biopsies in women with infertility of tubal origin. Fertil Steril 1989; 52: 232–8.
22. Karam GH, Martin DH, Flotte TR, et al. Asymptomatic Chlamydia trachomatis infections among sexually active men. J Infect Dis 1986; 154: 900–3.